ADMA Biologics
ADMA
#4061
Rank
A$4.41 B
Marketcap
A$19.90
Share price
-1.27%
Change (1 day)
-25.20%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2026 (TTM): A$0.35 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are A$0.51 Billion. In 2025 the company made an earning of A$0.28 Billion, an increase over its 2024 earnings that were of A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.35 B24.52%
2025 A$0.28 B35.89%
2024 A$0.21 B-4446.66%
2023 -A$4.86 Million-93.11%
2022 -A$70.45 Million-20.42%
2021 -A$88.52 Million-8.11%
2020 -A$96.34 Million62.31%
2019 -A$59.36 Million-34.76%
2018 -A$90.99 Million48.79%
2017 -A$61.15 Million134.28%
2016 -A$26.1 Million7.12%
2015 -A$24.37 Million0.3%
2014 -A$24.3 Million7.85%
2013 -A$22.53 Million71.04%
2012 -A$13.17 Million28864%
2011 -A$0.05 Million35.22%
2010 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
A$46.34 M-87.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.34 Billion-191.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$33.63 Million-109.08%๐Ÿ‡บ๐Ÿ‡ธ USA